SALVADOR ACEVEDO: Open Payments
NPI 1912630328 · RAYMONDVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 52 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,827 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 28 | $489 |
| Inspire Medical Systems, Inc. | 2 | $162 |
| Novo Nordisk Inc | 10 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| PFIZER INC. | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Heron Therapeutics, Inc. | 1 | $30 |
| Optinose US, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: ZEPBOUND, MOUNJARO, INSPIRE, Ozempic, Rybelsus, Kerendia, NURTEC ODT, FARXIGA.
Industry payments across TX — which companies pay providers there.
